background
influenza
major
caus
morbid
mortal
greatest
burden
elderli
patient
chronic
comorbid
intens
care
unit
icu
accur
prognosi
essenti
decisionmak
pandem
well
interpandem
period
method
retrospect
cohort
studi
conduct
determin
prognost
factor
influenc
short
term
outcom
critic
ill
patient
confirm
influenza
viru
infect
baselin
characterist
laboratori
diagnost
find
icu
intervent
complic
abstract
medic
record
use
standard
definit
compar
hospit
survivor
nonsurvivor
univari
multivari
logist
regress
analys
result
patient
met
inclus
criteria
acut
respiratori
distress
syndrom
ard
complic
icu
cours
patient
mortal
rate
multivari
logist
regress
analysi
identifi
follow
predictor
hospit
mortal
acut
physiolog
chronic
health
evalu
apach
iii
predict
mortal
odd
ratio
confid
interv
ci
increas
ard
ci
histori
immunosuppress
ci
conclus
apach
iii
predict
mortal
develop
ard
histori
immunosuppress
independ
risk
factor
hospit
mortal
critic
ill
patient
confirm
influenza
viru
infect
publish
elsevi
bv
background
influenza
major
caus
morbid
mortal
greatest
burden
elderli
patient
chronic
comorbid
intens
care
unit
icu
accur
prognosi
essenti
decisionmak
pandem
well
interpandem
period
method
retrospect
cohort
studi
conduct
determin
prognost
factor
influenc
short
term
outcom
critic
ill
patient
confirm
influenza
viru
infect
baselin
characterist
laboratori
diagnost
find
icu
intervent
complic
abstract
medic
record
use
standard
definit
compar
hospit
survivor
nonsurvivor
univari
multivari
logist
regress
analys
result
patient
met
inclus
criteria
acut
respiratori
distress
syndrom
ard
complic
icu
cours
patient
mortal
rate
multivari
logist
regress
analysi
identifi
follow
predictor
hospit
mortal
acut
physiolog
chronic
health
evalu
apach
iii
predict
mortal
odd
ratio
confid
interv
ci
increas
ard
ci
histori
immunosuppress
ci
conclus
apach
iii
predict
mortal
develop
ard
histori
immunosuppress
independ
risk
factor
hospit
mortal
critic
ill
patient
confirm
influenza
viru
infect
publish
elsevi
bv
season
influenza
acut
respiratori
ill
caus
influenza
b
virus
occur
everi
year
caus
hospit
death
unit
state
year
although
uncertain
next
panabbrevi
icu
intens
care
unit
ard
acut
respiratori
distress
syndrom
apach
acut
physiolog
chronic
health
evalu
odd
ratio
ci
confid
interv
copd
chronic
obstruct
pulmonari
diseas
ali
acut
lung
injuri
mv
mechan
ventil
niv
noninvas
mechan
ventil
cpap
continu
posit
airway
pressur
cdc
center
diseas
control
sar
sever
acut
respiratori
syndrom
acip
advisori
committe
immun
practic
sd
standard
deviat
iqr
interquartil
rang
demic
influenza
happen
even
season
influenza
pose
major
challeng
hospit
essenti
understand
determin
prognosi
patient
season
influenza
requir
respiratori
support
icu
admiss
need
mechan
ventil
sever
ill
previous
identifi
poor
prognost
factor
influenza
howev
specif
prognost
featur
includ
presenc
complic
acut
respiratori
distress
syndrom
ard
bacteri
superinfect
effect
vaccin
statu
systemat
studi
conduct
observ
cohort
studi
determin
outcom
patient
laboratori
proven
influenza
admit
icu
two
academ
medic
center
identifi
specif
prognost
featur
associ
mortal
morbid
patient
popul
retrospect
cohort
studi
includ
consecut
patient
laboratori
proven
influenza
admit
icu
mayo
clinic
rochest
mn
bed
close
medic
icu
univers
virginia
charlottesvil
va
bed
close
medic
icu
studi
approv
institut
review
board
institut
laboratori
proven
influenza
viru
infect
defin
follow
one
sign
symptom
flulik
ill
includ
abrupt
onset
fever
cough
headach
myalgia
accompani
laboratori
evid
influenza
viru
infect
test
influenza
perform
rapid
antigen
test
polymeras
chain
reaction
viral
cultur
immunohistochem
stain
influenza
b
respiratori
secret
acut
physiolog
chronic
health
evalu
apach
iii
score
prospect
collect
probabl
death
calcul
base
data
first
h
icu
admiss
immunosuppress
defin
therapi
immunosuppress
chemotherapi
radiat
long
termrec
high
dose
steroid
activ
leukemia
lymphoma
aid
acut
lung
injuri
ali
ard
defin
accord
americaneuropean
consensu
confer
primari
secondari
bacteri
infect
defin
accord
center
diseas
control
cdc
criteria
stepwis
multipl
logist
regress
procedur
perform
evalu
independ
impact
variabl
hospit
mortal
clinic
import
variabl
associ
outcom
interest
p
univari
analysi
introduc
forward
stepwis
logist
regress
model
take
consider
clinic
plausibl
colinear
variabl
jmp
comput
softwar
sa
institut
cari
nc
use
analysi
pvalu
consid
statist
signific
total
patient
male
caucasian
mean
age
admit
medic
icu
two
tertiari
care
hospit
patient
mayo
clinic
older
vs
p
sever
ill
similar
center
median
apach
iii
score
vs
p
patient
admit
hospit
novemb
april
influenza
case
influenza
b
case
number
influenza
case
observ
period
shown
fig
differ
mortal
influenza
influenza
b
vs
p
sixtyfour
patient
preexist
chronic
pulmonari
diseas
immunosuppress
patient
receiv
influenza
vaccin
hospit
admiss
although
vast
major
elig
routin
vaccin
base
age
andor
chronic
diseas
criteria
note
sd
standard
deviat
copd
chronic
obstruct
pulmonari
diseas
apach
iii
acut
physiolog
chronic
health
evalu
iii
iqr
interquartil
rang
intervent
complic
icu
admiss
two
center
retrospect
cohort
studi
confirm
signific
mortal
morbid
critic
ill
patient
laboratori
proven
season
influenza
poor
prognost
featur
includ
develop
ard
histori
immunosuppress
higher
sever
ill
although
patient
elig
vaccin
observ
strikingli
low
vaccin
rate
studi
also
confirm
high
frequenc
aureu
superinfect
patient
influenza
similar
previou
report
similar
previou
studi
hospit
patient
sever
ill
associ
increas
hospit
mortal
rate
cohort
importantli
find
suggest
death
interpandem
period
commonli
associ
ard
similar
pandem
find
import
risk
factor
develop
ard
mortal
immunosuppress
mechan
develop
ard
associ
influenza
still
undetermin
may
includ
direct
cytotox
apoptosi
alveolar
epitheli
cell
well
modif
host
inflammatori
respons
without
concurr
secondari
bacteri
infect
recent
angiotensin
convert
enzym
receptor
identifi
key
target
alveolar
cell
cytotox
secondari
sever
acut
respiratori
syndrom
sar
interpandem
period
patient
influenza
pneumonia
like
underli
cardiopulmonari
diseas
mortal
report
half
patient
cohort
histori
chronic
lung
diseas
pool
cohort
studi
publish
metaanalys
demonstr
small
signific
reduct
mortal
vaccin
elderli
individu
vs
unvaccin
individu
studi
patient
admit
icu
laboratori
confirm
influenza
vaccin
although
vast
major
vaccin
elig
base
either
age
chronic
comorbid
criteria
accord
advisori
committe
immun
practic
acip
criteria
although
degre
protect
elderli
patient
less
afford
healthi
younger
adult
find
potenti
indirectli
support
benefit
influenza
vaccin
vulner
patient
popul
vaccin
rate
antivir
therapi
import
strategi
control
influenza
diseas
efficaci
agent
limit
time
administr
good
result
obtain
antivir
treatment
start
within
h
inocul
studi
show
good
result
antivir
treatment
start
h
patient
acut
respiratori
failur
secondari
influenza
often
enter
icu
day
onset
symptom
viral
load
respiratori
secret
alreadi
high
make
difficult
evalu
efficaci
antivir
therapi
studi
sinc
minor
patient
admit
icu
meet
clinic
definit
influenza
actual
get
laboratori
test
studi
like
grossli
underestim
incid
influenza
viru
infect
skew
result
toward
sicker
patient
high
complic
rate
consequ
prognost
featur
may
generaliz
inform
domin
circul
subtyp
strain
collect
studi
period
make
difficult
evalu
effect
vaccin
conclus
critic
ill
associ
laboratori
proven
influenza
interpandem
period
mimic
pandem
find
high
preval
ard
complic
poor
prognosi
associ
ard
better
understand
mechan
develop
devast
complic
need
develop
effect
prevent
therapeut
strategi
low
vaccin
rate
cohort
predominantli
elderli
patient
high
frequenc
underli
chronic
lung
diseas
immunosuppress
indirectli
support
larg
scale
qualiti
improv
effort
aim
mandatori
vaccin
vulner
popul
